This last week, the United Nations Secretary-General’s High-Level Panel on Access to Medicines (HLP) published their highly anticipated report on global health technologies. Their report addressed some challenges of ensuring that medical innovations reach underserved populations, a topic central to Sabin’s mission. Specifically, the report gives recommendations for resolving policy incoherencies between public health objectives, human rights principles and international trade regulations.